0.655 USD
0 (-0.62%)
0.65 USD
-0.01 (-0.76%)
We assign a fundamental rating of 0 out of 10 to COCH. COCH was compared to 186 industry peers in the Health Care Equipment & Supplies industry. COCH has a bad profitability rating. Also its financial health evaluation is rather negative. COCH does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
- COCH had negative earnings in the past year.
- In the past year COCH has reported a negative cash flow from operations.
- In the past 5 years COCH reported 4 times negative net income.
- In the past 5 years COCH always reported negative operating cash flow.
1.2 Ratios
- COCH has a worse Return On Assets (-349.72%) than 93.01% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -349.72% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-205.35%
ROA(5y)-123.22%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- COCH does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- COCH does not have a ROIC to compare to the WACC, probably because it is not profitable.
- COCH has more shares outstanding than it did 1 year ago.
- COCH has a worse debt/assets ratio than last year.
2.2 Solvency
- Based on the Altman-Z score of -60.27, we must say that COCH is in the distress zone and has some risk of bankruptcy.
- COCH has a Altman-Z score of -60.27. This is amonst the worse of the industry: COCH underperforms 93.01% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -60.27 |
ROIC/WACCN/A
WACC8.34%
2.3 Liquidity
- A Current Ratio of 0.64 indicates that COCH may have some problems paying its short term obligations.
- With a Current ratio value of 0.64, COCH is not doing good in the industry: 91.40% of the companies in the same industry are doing better.
- COCH has a Quick Ratio of 0.64. This is a bad value and indicates that COCH is not financially healthy enough and could expect problems in meeting its short term obligations.
- COCH has a Quick ratio of 0.46. This is amonst the worse of the industry: COCH underperforms 91.94% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.64 | ||
| Quick Ratio | 0.46 |
3. Growth
3.1 Past
- The earnings per share for COCH have decreased by -4.44% in the last year.
- Looking at the last year, COCH shows a very negative growth in Revenue. The Revenue has decreased by -25.18% in the last year.
EPS 1Y (TTM)-4.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.11%
Revenue 1Y (TTM)-25.18%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-25%
3.2 Future
- Based on estimates for the next years, COCH will show a small growth in Earnings Per Share. The EPS will grow by 7.35% on average per year.
- Based on estimates for the next years, COCH will show a decrease in Revenue. The Revenue will decrease by -5.23% on average per year.
EPS Next Y18.83%
EPS Next 2Y7.35%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-28.14%
Revenue Next 2Y-5.23%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for COCH. In the last year negative earnings were reported.
- Also next year COCH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.35%
EPS Next 3YN/A
5. Dividend
5.1 Amount
- No dividends for COCH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
0.655
0 (-0.62%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-10 2025-11-10/bmo
Earnings (Next)03-31 2026-03-31/amc
Inst Owners5.9%
Inst Owner Change0.09%
Ins Owners37.08%
Ins Owner Change0%
Market Cap18.86M
Revenue(TTM)208.00K
Net Income(TTM)-28.61M
Analysts82.86
Price Target8.41 (1183.97%)
Short Float %2.74%
Short Ratio1.57
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend0.12
Dividend Growth(5Y)N/A
DP-8.51%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-4.36%
Min EPS beat(2)-7.53%
Max EPS beat(2)-1.2%
EPS beat(4)1
Avg EPS beat(4)-7.96%
Min EPS beat(4)-39.48%
Max EPS beat(4)16.38%
EPS beat(8)1
Avg EPS beat(8)-23.26%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-11.76%
Min Revenue beat(2)-41.18%
Max Revenue beat(2)17.65%
Revenue beat(4)1
Avg Revenue beat(4)-26.62%
Min Revenue beat(4)-50.59%
Max Revenue beat(4)17.65%
Revenue beat(8)2
Avg Revenue beat(8)-24.44%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)10%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.03%
EPS NY rev (1m)3.42%
EPS NY rev (3m)10.14%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-21.43%
Revenue NY rev (1m)3.63%
Revenue NY rev (3m)-12.54%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 90.66 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.41
EYN/A
EPS(NY)-1.2
Fwd EYN/A
FCF(TTM)-0.57
FCFYN/A
OCF(TTM)-0.59
OCFYN/A
SpS0.01
BVpS-0.27
TBVpS-0.27
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -349.72% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-205.35%
ROA(5y)-123.22%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.03
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 195.19% | ||
| Cap/Sales | 253.37% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.64 | ||
| Quick Ratio | 0.46 | ||
| Altman-Z | -60.27 |
F-Score2
WACC8.34%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.11%
EPS Next Y18.83%
EPS Next 2Y7.35%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-25.18%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-25%
Revenue Next Year-28.14%
Revenue Next 2Y-5.23%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y4.93%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-14.25%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-136.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-148.72%
OCF growth 3YN/A
OCF growth 5YN/A
ENVOY MEDICAL INC / COCH FAQ
What is the fundamental rating for COCH stock?
ChartMill assigns a fundamental rating of 0 / 10 to COCH.
What is the valuation status of ENVOY MEDICAL INC (COCH) stock?
ChartMill assigns a valuation rating of 0 / 10 to ENVOY MEDICAL INC (COCH). This can be considered as Overvalued.
How profitable is ENVOY MEDICAL INC (COCH) stock?
ENVOY MEDICAL INC (COCH) has a profitability rating of 0 / 10.
Can you provide the dividend sustainability for COCH stock?
The dividend rating of ENVOY MEDICAL INC (COCH) is 0 / 10 and the dividend payout ratio is -8.51%.